SANBIO

SanBio is focused on regenerative cell medicines for neurological disorders such as stroke, traumatic brain injury, diseases of the eye, and Parkinson's disease. SB643 is in Clinical Trials for Stroke and Traumatic Injury... SanBios regenerative cell medicine employs allogeneic transplantation, compared to the laborious, time-consuming, and costly process of autologous transplantation, it is expected to produce large qualities of homogenous products at lower costs. Sanbio aims to deliver medical care to as many patients as possible.

Also known as: SanBio Asia Pte. Ltd., SanBio Co, SanBio Co,Ltd., SanBio Company Limited, SanBio, Inc., SanBio, Ltd.

Primary location: Mountain View United States